https://globalinfectiousdisease.com/research/ Published infectious-disease literature filtered to Botswana. en Wed, 09 Sep 2026 07:02:01 GMT https://globalinfectiousdisease.com/research/articles/10-1038-s41586-022-04594-4-de28a769/ https://globalinfectiousdisease.com/research/articles/10-1038-s41586-022-04594-4-de28a769/ Thu, 03 Mar 2022 00:00:00 GMT The findings indicate that the three Omicron sublineages are antigenically equidistant from wild-type SARS-CoV-2 and similarly threaten current vaccine efficacy. No authorized monoclonal antibody therapy except bebtelovimab adequately covers all Omicron sublineages. SARS COVID-19 Outbreak investigation Surveillance Treatment Journal article